Sharing success - understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease

Background: Rheumatic fever (RF) and rheumatic heart disease (RHD) cause considerable morbidity and mortality amongst Australian Aboriginal and Torres Strait Islander populations. Secondary antibiotic prophylaxis in the form of 4-weekly benzathine penicillin injections is the mainstay of control programs. Evidence suggests, however, that delivery rates of such prophylaxis are poor. Methods: This qualitative study used semi-structured interviews with patients, parents/care givers and health professionals, to explore the enablers of and barriers to the uptake of secondary prophylaxis. Data from participant interviews (with 11 patients/carers and 11 health practitioners) conducted in four far north Queensland sites were analyzed using the method of constant comparative analysis. Results: Deficits in registration and recall systems and pain attributed to injections were identified as barriers to secondary prophylaxis uptake. There were also varying perceptions regarding responsibility for ensuring injection delivery. Enablers of secondary prophylaxis uptake included positive patient-healthcare provider relationships, supporting patient autonomy, education of patients, care givers and healthcare providers, and community-based service delivery. Conclusion: The study findings provide insights that may facilitate enhancement of secondary prophylaxis delivery systems and thereby improve uptake of secondary prophylaxis for RF/RHD

PLIF Measurements of Nitric Oxide and Hydroxyl Radicals Distributions in Swirled Stratified Premixed Flames

Environmental and economic concerns have pushed aeronautical authorities to set stringent environmental regulations on fuel consumption, noise production, and pollutant emission. Engine manufacturers are developing novel staged injection concepts to ensure their respect. The injection staging creates a fuel-air mixture stratification involving new combustion processes not fully understood. This paper presents the experimental investigation of NO production for known swirled and / or stratified lean premixed flames. The fuel staging parameter defined as the stratification ratio is studied for values of 1, 2, and 3, while the swirl fractions are 0, 25 and 33%, changing the flowfield from non-swirling cond itions to high swirl numbers (up to 0.55). The implementation of simultaneous OH- and NOPLIF imaging techniques is achieved using high energy pulsed laser systems, able, for instance, to deliver 30 mJ/ pulse around the 226-nm UV wavelength for NO excitation. OH-PLIF is used to characterize the flame structure through the commonly extracted curvature, and also through the measurement of the flame thickness. These results show to be more accurate than thickness obtained from temperature profiles measured by Raman/ Rayleigh laser diagnostics. NO-PLIF is used to quantify the pollutant concentration. To this end, preliminary work was done to select the Q1 (29.5) transition as it the least temperature dependent excitation scheme with high fluorescence levels. After realizing a specific calibration of the NO-PLIF technique, the stud ied flames presented concentrations ranging from traces (20 ppm) to high levels (230 ppm). Further analysis of these results reveals that for high stratification ratios the prompt NO is favored and is responsible for the elevated level of NO pollutant

Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments

International audienceFunctions of septin cytoskeletal polymers in tumorigenesis are still poorly defined. Their role in the regulation of cytokinesis and cell migration were proposed to contribute to cancer associated aneuploidy and metastasis. Overexpression of Septin 9 (Sept9) promotes migration of cancer cell lines. SEPT9 mRNA and protein expression is increased in breast tumors compared to normal and peritumoral tissues and amplification of SEPT9 gene was positively correlated with breast tumor progression. However, the existence of multiple isoforms of Sept9 is a confounding factor in the analysis of Sept9 functions. In the present study, we analyze the protein expression of Sept9_i2, an uncharacterized isoform, in breast cancer cell lines and tumors and describe its specific impact on cancer cell migration and Sept9 cytoskeletal distribution. Collectively, our results showed that, contrary to Sept9_i1, Sept9_ i2 did not support cancer cell migration, and induced a loss of subnuclear actin filaments. These effects were dependent on Sept9_i2 specific N-terminal sequence. Sept9_i2 was strongly down-regulated in breast tumors compared to normal mammary tissues. Thus our data indicate that Sept9_i2 is a negative regulator of breast tumorigenesis. We propose that Sept9 tumorigenic properties depend on the balance between Sept9_i1 and Sept9_i2 expression levels

Radiotherapy modification based on artificial intelligence and radiomics applied to (18F)-fluorodeoxyglucose positron emission tomography/computed tomography.

peer reviewedOver the last decades, the refinement of radiation therapy techniques has been associated with an increasing interest for individualized radiation therapy with the aim of increasing or maintaining tumor control and reducing radiation toxicity. Developments in artificial intelligence (AI), particularly machine learning and deep learning, in imaging sciences, including nuclear medecine, have led to significant enthusiasm for the concept of "rapid learning health system". AI combined with radiomics applied to (18F)-fluorodeoxyglucose positron emission tomography/computed tomography ([18F]-FDG PET/CT) offers a unique opportunity for the development of predictive models that can help stratify each patient's risk and guide treatment decisions for optimal outcomes and quality of life of patients treated with radiation therapy. Here we present an overview of the current contribution of AI and radiomics-based machine learning models applied to (18F)-FDG PET/CT in the management of cancer treated by radiation therapy

CV13016

Use the URI link below to search the Marine Institute Data Discovery Catalogue for datasets relevant to this report.This report provides the results of the second underwater television on the ‘Porcupine Bank Nephrops grounds’ ICES assessment area; Functional Unit 16. The survey was multi-disciplinary in nature collecting UWTV, CTD and other ecosystem data. In total 68 UWTV stations were successfully completed in a randomised 6 nautical mile isometric grid covering the full spatial extent of the stock. The mean burrow density observed in 2013, adjusted for edge effect, was 0.106 burrows/m². The final krigged abundance estimate was 768 million burrows with a relative standard error of 4% and an estimated stock area of 7,100km2. The abundance estimate was 2% lower than in 2012. Landings options at various different fishing mortalities were calculated in line with the recommendations of WKNEPH 2013. Fishing at Fmsy in 2014 implies a slight increase in the TAC from 1,800 t to 1,850 t. This increase is mainly due to an increase in average mean weight of the landings. The three species of sea-pen found on muddy habitat in Irish waters are Virgularia mirabilis, Funiculina quadrangularis and Pennatula phosphorea were all observed during the survey. Trawl marks were also observed on over half of the stations surveyed

Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells

<p>Abstract</p> <p>Background</p> <p>There is increasing evidence that the toll-like receptor 3 (TLR3) is an interesting target for anti-cancer therapy. Unfortunately, most laboratory investigations about the impact of TLR3 stimulation on human malignant cells have been performed with very high concentrations - 5 to 100 μg/ml - of the prototype TLR3 ligand, poly(I:C). In a previous study focused on a specific type of human carcinoma - nasopharyngeal carcinoma - we have shown that concentrations of poly(I:C) as low as 100 ng/ml are sufficient to induce apoptosis of malignant cells when combined to a pharmacological antagonist of the IAP family based on Smac mimicry.</p> <p>Methods</p> <p>This observation prompted us to investigate the contribution of the IAP family in cell response to poly(I:C) in a variety of human malignant cell types.</p> <p>Results</p> <p>We report a rapid, intense and selective increase in c-IAP2 protein expression observed under stimulation by poly(I:C)(500 ng/ml) in all types of human malignant cells. In most cell types, this change in protein expression is underlain by an increase in c-IAP2 transcripts and dependent on the TLR3/TRIF pathway. When poly(I:C) is combined to the IAP inhibitor RMT 5265, a cooperative effect in apoptosis induction and/or inhibition of clonogenic growth is obtained in a large fraction of carcinoma and melanoma cell lines.</p> <p>Conclusions</p> <p>Currently, IAP inhibitors like RMT 5265 and poly(I:C) are the subject of separate therapeutic trials. In light of our observations, combined use of both types of compounds should be considered for treatment of human malignancies including carcinomas and melanomas.</p